EPHA2 and renal cell carcinoma: EphA2 siRNA treatment promoted early or late apoptosis at 48 hours following transfection in the non-metastatic RCC cell lines (Caki-2 and A498) (Fig 4B), but not in the metastatic RCC cell lines (Caki-1 or ACHN) (Fig 4A).